CAS 1032568-63-0 appears in our catalog under these names: Copanlisib, Copanlisib/ 99.88% (existing batch purity), BAY 80–6946 (Copanlisib), Copanlisib 98%, Copanlisib, 99.35%. Offered by: Chemat Brand, TargetMol, GLPBio, Biosynth, Ambeed. Available pack sizes: on request, 2mg, 5mg, 10mg, 25mg, 50mg, 100mg, 5g.
Copanlisib is an imidazoquinazoline that is 2,3-dihydroimidazo[1,2-c]quinazoline substituted by (2-aminopyrimidine-5-carbonyl)amino, methoxy, and 3-(morpholin-4-yl)propoxy groups at positions 5, 7 and 8, respectively. It is a intravenous pan-class I PI3K inhibitor used for the treatment of relapsed follicular lymphoma in patients who have received at least 2 prior systemic therapies. It has a role as an antineoplastic agent, an EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor and an apoptosis inducer. It is a secondary carboxamide, an aromatic ether, an aminopyrimidine, a member of morpholines, a diether, an imidazoquinazoline, a pyrimidinecarboxamide and a tertiary amino compound.
Source: ChEBI
| Molecular formula | C23H28N8O4 |
|---|---|
| Molecular weight | 480.5 g/mol |
| IUPAC name | 2-amino-N-[7-methoxy-8-(3-morpholin-4-ylpropoxy)-2,3-dihydro-1H-imidazo[1,2-c]quinazolin-5-ylidene]pyrimidine-5-carboxamide |
| InChIKey | MWYDSXOGIBMAET-UHFFFAOYSA-N |
| SMILES | COC1=C(C=CC2=C3NCCN3C(=NC(=O)C4=CN=C(N=C4)N)N=C21)OCCCN5CCOCC5 |
Computed by PubChem (NCBI)